Integrated Management Program Advancing Community Treatment of Atrial Fibrillation

Not Applicable

Completed

Conditions: Atrial Fibrillation

Interventions: Other: Clinical Decision Support System for AF

Registration Number: NCT01927367

Lead Sponsor: Jafna L Cox

Brief Summary: Research Question: Among community-based patients with AF, does providing an integrated Clinical Decision Support System (CDSS) to providers and patients improve process of care and clinical outcomes, and decrease the healthcare costs and resource utilization over 12 months, as compared to usual care?

Intervention: A web-based clinical decision support system, computerizing the Canadian AF clinical guidelines, to support primary care providers and patients in optimizing and standardizing AF care.

Detailed Description: Atrial fibrillation (AF) is the most common abnormality of cardiac rhythm. It is also a disease of aging, affecting 3% of adults aged \> 45 years and 12% of those aged \> 75. Individually, AF's rapid and irregular heart beat is most frequently perceived as undesirable palpitations, but more threatening impacts are heart failure, catastrophic stroke and premature death. AF also markedly impairs quality of life.

Although patients with AF are at increased risk of stroke, death and hospitalization, many patients are not benefiting from evidence-informed, best-care strategies. Gaps have been documented in the knowledge, skills and competencies of primary care clinicians concerning the management of AF in Canada. For example, a large proportion of AF patients at moderate to high risk for stroke do not receive guideline recommended thromboprophylaxis; and of those that do, many are not optimally controlled. One Canadian study also found that in patient with known AF and a prior stroke, who were then admitted with a second stroke, 15% were not on any anticoagulation and only 18% were on warfarin and within the therapeutic range. Opportunities certainly exist to enhance the uptake of the Canadian AF Clinical Practice Guideline recommendations and best-care approaches in the primary care setting.

Patients need to be the focus of care services and be actively engaged and empowered to manage their care, with the support of health care providers. We believe that health system efficiency, care quality and patient safety can be enhanced through the use of innovative, integrated, interactive, pro-active and personalized point-of- care solutions targeting both providers and patients. This is the premise for the IMPACT-AF study.

Primary care providers and their patients are anticipated to benefit from enhanced use of health information technology regarding the management of patients with AF. A clinical guideline-based decision support system (CDSS) will be developed and tested in primary care settings across Nova Scotia.

Recruitment & Eligibility

Status: COMPLETED

Sex: All

Target Recruitment: 1145

Inclusion Criteria

Age >/= 18 years (no max age limit)
Confirmed atrial fibrillation.
Able to provide informed consent in English.

Exclusion Criteria

Patients unable to provide informed consent.
Patients who are not expected to be alive at the end of the 12 month follow up.

Study & Design

Study Type: INTERVENTIONAL

Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Clinical Decision Support System for AF	Clinical Decision Support System for AF	Providers randomized to use the Clinical Decision Support System (CDSS, a web-based tool).

Primary Outcome Measures

Name	Time	Method
Number of Participants With Cardiovascular Hospitalization and AF-related Emergency Department Visits	12 months	Any unplanned hospitalization (admission with an overnight stay in hospital) due to one of the following causes: acute coronary syndrome, pre-syncope /syncope, transient ischemic attack/ stroke, atrial fibrillation, flutter, pulmonary embolism /deep vein thrombosis /systemic embolism, worsening congestive heart failure including pulmonary edema or dyspnea of cardiac origin. AF-related ED visit was predefined as: any presentation with palpitations, rapid heart rate, presyncope or syncope, shortness of breath, transient chest discomfort, or hemodynamic instability resolving with cardioversion or rate-control, not resulting in hospitalization.

Secondary Outcome Measures

Name	Time	Method
Process of Care	12 months	* Timely access to specialist consultation * Timely access to echocardiograms * Timely access to catheter ablations for AF and atrial flutter
Costs	12 months	* The costs associated with the development, implementation, and maintenance of CDSS. * The costs associated with managing and treating patients with AF.
Number of Participations With CV Hospitalizations	12 months	* Individual element of primary outcome. * AF-related emergency department visits.
Health Related Quality of Life	12 months	- Health Related Quality of Life measured using an accepted health questionnaire (EQ-5D-5L).
Number of Participants With AF-related Emergency Department Visits	12 months	* Individual element of primary outcome. * AF-related emergency department visits.
Cost Effectiveness	12 months	- Incremental cost effectiveness ratio between the interventional arm and the control arm